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Abstract
The IFN-γ-inducible chemokines CXCL9, CXCL10, and CXCL11 play a key role in many
inflammatory conditions, particularly those mediated by T cells. Therefore, the production of
these chemokines in peripheral tissues could be instrumental in the pathophysiology of tis-
sue-specific immunological diseases such as oral lichen planus (OLP). In the present study,
we assessed the production of keratinocyte-derived CXCL9/10/11 under basal and inflamma-
tory conditions and investigated whether these chemokines were involved in the pathogenesis
of OLP. We used semi-quantitative PCR, ELISA, chemotaxis assays, and fluorescence-acti-
vated cell sorting (FACS) to assess the expression and functional role of CXCL9/10/11 in oral
keratinocytes (three strains of normal human oral keratinocytes (NHOK), and the H357 oral
cancer cell line) in the presence or absence of IFN-γ. CXCL9/10/11 were also assessed in tis-
sues from normal patients and those with oral lichen planus (OLP). The time course study in
oral keratinocytes treated with IFN-γ showed that expression of CXCL9/10/11 chemokines
was significantly enhanced by IFN-γ in a time-dependent manner. In particular, CXCL10, a
prominent chemokine that was overexpressed by IFN-γ-stimulated NHOK, was able to effec-
tively recruit CD4 lymphocytes, mainly CD4+CD45RA- cells. Significantly higher levels of
CXCL9/10/11 were found in tissues from patients with OLP compared to normal oral mucosa.
Taken together, the results demonstrate that normal oral keratinocytes produce chemotactic
molecules that mediate T cell recruitment. This study furthers understanding of chemokine
production in oral keratinocytes and their role in the pathophysiology of oral mucosa, with par-
ticular relevance to OLP.
Introduction
Interferon-γ (IFN-γ), also known as immune type II interferon, is a pleiotropic cytokine secreted
by CD4 Th1, CD8, γδ T, and natural killer (NK) cells. Its main functions encompass regulation of
the immune system and the control of infectious disease. This Th1 cytokine plays an essential
role in both the innate and adaptive phases of an immune response [1,2]. Interestingly, IFN-γ
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and other Th 1 cytokines have been demonstrated to regulate the immunological activity in T-
cell-mediated inflammation of the oral mucosa, such as in OLP [3,4]. One of the mechanisms by
which IFN-γ exerts its immunological function is by inducing the production of a subset of pro-
inflammatory chemokines that stimulate leukocyte migration and takes part in the regulation of
leukocyte trafficking through lymphoid tissues [5,6].
Three such chemokines induced by IFN-γ, i.e. monokine induced by IFN-γ (MIG) (CXCL9),
IFN-induced protein-10 (IP-10) (CXCL10) and IFN-γ induced T-cell attractant chemokine
(I-TAC) (CXCL11), belong to the CXC family and are characterised by the lack of a Glu-leu-arg
(ELR) motif [7]. CXCL9/10/11 all bind the CXCR3 receptor [8–10], which is predominately
expressed on activated/memory CD4/CD8 cells [8,11,12] that are associated with a Th1 pheno-
type [13], and on dendritic cells and natural killer cells, but also fibroblasts and smooth muscle,
epithelial and endothelial cells [14]. These IFN-γ-inducible chemokines can be produced by a
number of different cell types including haemopoetic cell types, e.g. macrophages and neutrophils
[15,16] and non-haemopoetic cell types, such as endothelial cells [17], fibroblasts [15,18], and epi-
thelial cells [19–21], including skin keratinocytes [9,22,23], some human oral SCC cell lines [24],
as well as one immortalized oral keratinocyte cell line [18]. However, the expression of CXCR3-
binding chemokines in primary oral keratinocytes and normal oral mucosal tissues has not been
convincingly demonstrated so far.
The production of CXCL9, CXCL10 and CXCL11 is associated with many T cell mediated
conditions like organ rejection [15,25,26], autoimmune conditions [27], rheumatoid arthritis
[12,28], inflammatory bowel diseases [12,29] and airway inflammation [30]. These chemokines
are also characteristic of certain skin inflammatory disorders, such as contact hypersensitivity
[31–34], interface dermatitis [35], Lichenoid graft-versus-host disease (liGVHD) [35] and
lichen planus [9,18,31, 36–38], where the chemokines are produced in abundance in the dis-
eased tissues. The identification of these chemokines in oral inflammation [39], suggests that
these are also influential in the infiltration of T cells to oral mucosa. As OLP is a condition
characterised by a large T cell infiltrate localised in a band-like pattern directly beneath the
basal epithelium, and because IFN-γ is instrumental in the immunopathogenesis of OLP [40],
we hypothesized that an IFN-γ-induced local production of pro-inflammatory chemokines by
oral keratinocytes could potentially represent an important mechanism involved in T cell
recruitment.
In the present study, we investigated the expression pattern of the CXCR3-binding chemo-
kines CXCL9/10/11 in normal human oral keratinocytes (NHOK) after IFN-γ treatment, in
order to assess whether these chemokines can be induced under IFN-γ stimulation in the oral
epithelium, and thus may be able to promote T cell migration to the oral epithelial tissues. The
potential role that these three chemokines play in oral inflammation was evaluated by assessing
the relative level of CXCR3-binding chemokines mRNA in OLP and normal oral mucosal
tissue.
Materials & methods
Patients
All OLP tissue was collected from patients that were attending the Oral Medicine Clinic, Eastman
Dental Institute. The diagnosis of OLP was assessed clinically by two oral medicine specialists
(M.M. and S.P.) according to well established criteria,and confirmed histopathologically. The
medical history of the patients included in this study was carefully revised, and didn’t include any
concomitant pharmacological treatment, hematological anomalies or systemic disease. All nor-
mal oral mucosa was obtained from patients attending the Oral Surgery Clinic, Eastman Dental
Institute for routine third molar extraction. A total number of 54 samples (36 OLP and 18 NOM)
CXCL9/10/11 regulation in oral keratinocytes
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were collected. The internal Ethical Committee of the UCL Eastman Dental Institute approved
the study protocol, which was performed in accordance with the tenets of the Declaration of Hel-
sinki. All patients provided written informed consent.
Cell culture techniques
Normal human oral keratinocytes (NHOK) cell culture. Normal oral mucosal tissue
was obtained for this study from healthy patients. Three different NHOK strains (NHOK1,
NHOK2, NHOK3) were isolated from the excised normal tissue by separating the connective
tissue. The samples were cut into approximately 1mm3 pieces and culturing at 37˚C /5% CO2
in keratinocyte basal medium-2 containing the recommended growth supplements (Biowit-
taker, Wokingham, UK). The epithelial cells were then detached using 0.25% trypsin-1mM
EDTA. The viability of the keratinocytes was confirmed by trypan blue exclusion.
H357 cell culture. The oral squamous cell carcinoma cell line, H357, was established by
Prime et al [41], from a primary explant of a tongue squamous cell carcinoma. This cell line
was grown in the same medium as described for the NHOK.
IFN-γ cell treatment assay
In a modification of the method utilised by Altenburg et al [42], the NHOK1, NHOK2, NHOK3
and the H357 cell line (at 2nd or 3rd passage) were seeded at 8x104cells/ well in a Falcon 6 well
plate (Becton Dickinson, Oxford, UK) with 3mls of KBM-2 medium containing no hydrocorti-
sone. The cells were incubated for at least 3–5 days until cell culture was 60–80% confluent. We
set up the optimal experimental conditions in preliminary experiments with dose-response
curves. Medium containing human recombinant 1000U/ml IFN-γ (catalogue number I3265,
purity 98%, Sigma–Aldrich, Poole, UK) was added to 3 wells and control cell culture medium
only was added to the remaining 3 wells. The 1000U/ml concentration of IFN-γ had been suc-
cessfully used by previous studies to stimulate keratinocytes in vitro [42–45]. The cells were incu-
bated for 48hrs or, in the case of the H357 time course, for the following time-points: 3hrs, 6hrs,
9hrs, 24hrs, 48hrs and 72hrs. The supernatant was extracted, centrifuged and stored at –70˚C.
The adherent cells were washed with PBS (Gibco Life Technologies, Paisley, UK) before 0.5ml of
Trireagent were added. The suspension was then removed and stored at –70˚C. The RNA was
isolated as described below.
mRNA isolation and semi-quantitative RT-PCR
OLP and normal oral mucosa (NOM) tissue were obtained and prepared for RNA isolation.
RNA isolation and cDNA synthesis of NHOK, H357, NOM and OLP tissue was carried out.
The RNA was extracted according to the manufacturer’s instructions, utilising 2ul Pellet Paint
Co-precipitant (Novagen, Nottingham, UK) to visualise the RNA pellet. The purified RNA
was dissolved into 25ul DEPC water (Ambion, Austin, US) and stored at -70˚C.
All procedures for the cDNA Single strand synthesis were carried out on ice. 2ul of RNA was
added to 4ul deoxynucleotides (dNTPs) (2.5mM) (Sigma), 2ul of random hexamers (50um)
(Ambion, Texas, USA) and 9.5ul dH2O. This was incubated at 70˚C for 3 minutes and allowed
to cool at room temperature. Then 1ul of RNAaseIN (Ambion, Austin, Texas, USA), 2ul 10x
MuLVRT buffer and 0.5ul M-MuLVRT (200U/ul) (Boehringer-Mannheim, Germany) was
added and incubated at 42˚C for 1 hour. cDNA samples were stored at –20˚C.
CXCL9 (5’-ccaacaccccacagaagtgc–3’,5’-gccagcacctgctctgagac-3’),
CXCL10 (5’- gccaattttgtccacgtgttg-3’, 5’-aaagaatttgggccccttgg-
3’),
CXCL9/10/11 regulation in oral keratinocytes
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CXCL11 (5’-ggcttccccatgttcaaag –3’, 5’-cagatgcccttttccaggac-3’)
and primers were generated for use in this study (Genosys-Sigma, Poole, UK). The thermocy-
cler (Techne Genius, Cambridge, UK) parameters utilised were at 94˚C for 45secs, 57˚C for
45secs, 72˚C for 45secs.
CXCL9/10/11 primers (as described above) were utilised with QuantamRNA 18S internal
standards (Ambion, Texas, USA). The primers utilised for the study of housekeeping expres-
sion encoded a region of 18S ribosomal RNA (5’- tttcggaactgaggccatga-3’, 5’-
gcatgccagagtctcgttcg-3’).
For each primer the linear range was determined by repeating the above reaction with opti-
mised magnesium concentration for each primer and stopping the reaction at 15, 17, 19, 21, 23,
25, 27, 29, 31, 33 and 35 cycles. The mid-point of each linear range was determined by using
intensity analysis of the bands with AlphaImager software, and this cycle length was utilised for
each primer in subsequent reactions. 18S primer and 18S Competitor primers (Ambion, Texas,
USA) were combined to ratios 1:9, 2:8 and 3:7 respectively. For each of the primers (CXCL9/10/
11) 4μl of the 18S primer competitor mix was added to the RT-PCR reaction and the results
were compared to the reactions containing the specific primers without any 18S primer. The
reaction that had the same level of specific primer expression as that without 18S primer added
was selected for quantification. The band intensity of the 18S and of the specific primer was
quantified in each sample with Phoretix 1D software (Phoretix, Newcastle, UK).
Enzyme-linked immunosorbant assay (ELISA)
A 96 well maxisorp-surface immunoplate (Nunc, Denmark) was coated overnight with a mono-
clonal antibody against the human protein to be studied. The plate was then washed 3 times
with wash buffer (2.5mMNa2HPO4 (BDH), 0.5mM NaCl (BDH), 7.5mM NaH2PO4.2H2O
(BDH) and 0.1% of Tween 20 (BDH). 100ml of cell supernatant or positive control (in a range
of dilutions to obtain a standard curve) was added and incubated for 2 hours at room tempera-
ture then washed. A biotinylated antibody was used as a secondary antibody; 100μl of this anti-
body, diluted to an appropriate concentration, was added to each well. The plate was sealed and
incubated for 1 hour at room temperature, then washed 3 times. Bound secondary antibody
was detected by adding 100μl avidin-HRP (Dako, Denmark) [diluted 1:4000] and incubating
for 30 minutes at room temperature. 25ml H2O2 was added to OPD (1 tablet of o-phenyl diami-
nazadine (Sigma, Poole, Dorset) in 25ml of 34.7mM citric acid, 66.7mM Na2HPO4) and 100μl
of this solution was dispensed to each well immediately and incubated at room temperature for
15 mins. The reaction was stopped by adding 100ml of 1M sulphuric acid to the wells and the
absorbance measured at 490nM. Chemokine concentration in the supernatant was then extrap-
olated from the standard curve generated from standards using Revelation software (Dynex
Technologies, Virginia, US) attached to an ELISA plate reader (Dynex Technologies, Virginia,
US).
Chemotaxis assay
Peripheral blood mononuclear cells (PBMC) were prepared from fresh blood obtained from
healthy patients. The lymphocyte separation was carried using Ficoll-Paque (Amersham)
according to the manufacturers instructions. Peripheral blood lymphocytes obtained were
incubated for 1hr in RPMI-1640 (Gibco Life Technologies, Paisley, UK) plus 5% foetal bovine
serum (Sigma, Poole, UK), and those cells remaining in suspension were adjusted to a density
of 5x106 cells/ml.
The cells were then migrated towards 1μg/ml recombinant human CXCL10 or 100mM
SDF-1alpha (R&D Systems, Minneapolis, US) in a transwell migration assay. 600μl of cell
CXCL9/10/11 regulation in oral keratinocytes
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culture supernatant from each sample was added to the bottom chamber of Corning Co-star
5μm pore transwells (BDH, UK) in triplicate. 100μl of PBL was added to the top chamber. The
transwells were then incubated for 3 hours at 37˚C in atmosphere containing 5% CO2. After
migration, the cells that passed through the membrane were collected and incubated with allo-
phycocyanin conjugated anti-human CD45RA (Clone HI100) and Cy-chrome conjugated
mouse anti-human CD4 (Clone RPA-T4) (Both BDPharmingen, San Diego, US) for 30 mins
at 3μl /106 cells. The migrated cell populations were then analysed using a florescence activated
cell sorter (FACS) machine (Becton Dickinson, Oxford, UK).
Statistical analysis
Unless otherwise specified all the experiments were performed at least in triplicate. All p values
in studies included in this paper were obtained by executing paired Student’s T test upon the
data, unless otherwise stated.
Results
Time course study of CXCL9/10/11 chemokine expression in
keratinocytes treated with IFN-γ
The production of CXCL9/10/11 chemokines in oral mucosal keratinocytes was first assessed
over time in preliminary experiments using the keratinocyte cell line H357. After three hours
of IFN-γ treatment, CXCL10 mRNA levels were detectable in H357 cells, with a peak at 24
hours. In contrast, the control cells showed virtually undetectable mRNA levels over the same
time period. CXCL9 mRNA transcripts demonstrated a similar pattern to CXCL10, with a
biphasic pattern showing a rapid induction of mRNA in the stimulated cells followed by a sec-
ond peak at 24/48 hours (Fig 1). CXCL11 underwent a time-dependent increase over 48hrs,
however mRNA transcripts were absent after 72hrs for all chemokines.
Interestingly, both CXCL9 and CXCL10 mRNA levels at 9 hours was virtually undetectable,
and this prompted us to confirm if these chemokines were indeed expressed at the protein
level. ELISA revealed a significant increase of CXCL10 protein at 9 hours, with a fairly stable
expression of CXCL9 protein at the same time point. CXCL10 production reached a peak of
262.6pg/ml after 48 hours of IFN-γ stimulation, with a significant increase starting as early as 3
and 6 hours after stimulation (Fig 2B). The concentration of CXCL9 produced by H357 cells
also reached a peak after 48 hours of IFN-γ incubation, but in contrast to CXCL10 this was the
only time point where the concentration of CXCL9 was significantly higher than control cells
(Fig 2A). The concentration of CXCL9 produced in IFN-γ-treated cells was lower than
CXCL10 at all time points and appeared to undergo a slower increase.
Taken together, the data show that expression of CXCL9/10/11 in H357 cells can be signifi-
cantly enhanced by IFN-γ in a time-dependent manner, with a peak after 48 hours.
Induction of CXCL9/10/11 chemokines in NHOK
Both CXCL9 and CXCL10 chemokines mRNA were expressed in IFN-γ stimulated primary
oral epithelial cells. Interestingly CXCL10, but not CXCL9, displayed low but detectable
mRNA expression in the untreated cells (Fig 3B and 3C) (S1 File). These data were confirmed
at the protein level by ELISA, which showed a highly significant increase of CXCL10 in all the
NHOKs (Fig 4). Weak CXCL11 mRNA expression was witnessed in the treated cells, but was
absent in the non-treated cells (Fig 3D).
CXCL9/10/11 regulation in oral keratinocytes
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Taken together, the data show that CXCL9/10/11 are overexpressed in NHOK upon IFN-γ
stimulation. In particular, constitutive CXCL10 production was significantly and consistently
enhanced by IFN-γ in all three keratinocyte strains.
CXCL10 induces the migration of specific subsets of T lymphocytes
To investigate if CXCL10 could serve as a chemotactic molecule, FACS analysis was used to
assess the migration of peripheral blood mononuclear cells (PBMC) in response to this chemo-
kine. The profile of lymphocytes that are attracted to CXCL10 and CXCL12 (SDF-1alpha),
another potent CXC chemokine used as control, are shown in Fig 5A and 5B. Whereas there is
a number of CD45RA+ and CD45RA- cells attracted to SDF in the CD4+ population (CD4+
CD45RA- gated cells are represented by the box on the graphs), CXCL10 cells attract mainly
CD4+CD45RA- cells from this population. Both CXCL10 and CXCL12 attract lymphocyte pop-
ulations above the rate of basal migration, including CD4+CD45RA- cells (Fig 5C and 5D).
Semi-quantification of CXCL9, CXCL10 and CXCL11 mRNA in OLP and
normal oral mucosa
Previous studies have failed to demonstrate the expression of CXCL9/10/11 in normal oral
mucosa [38, 18, 46], however our results show that primary oral keratinocytes can express
some of these chemokines under basal conditions. Therefore, studies to set up optimal experi-
mental conditions were undertaken. The idv (integrated density value) of CXCL9 (Fig 6A),
Fig 1. 18S (a), CXCL9 (b), CXCL10 (c) and CXCL11 (d) mRNA expression in the H357 cell line. (ifn) =
cells that were treated with IFN-γ for 3, 6, 9, 24, 48 or 72 hours; (con) = control cells that were left untreated
over the same time period.
doi:10.1371/journal.pone.0172821.g001
CXCL9/10/11 regulation in oral keratinocytes
PLOS ONE | DOI:10.1371/journal.pone.0172821 March 2, 2017 6 / 17
CXCL10 (Fig 6B) and CXCL11 (Fig 6C) mRNA specific bands after removing the RT-PCR
reactions at different cycle numbers is shown in Fig 6. The midpoint of the linear ranges of
CXCL9, CXCL10 and CXCL11 was calculated to be 23, 21 and 30 respectively, therefore these
cycle lengths were utilised for the following semi-quantitative study. The ratio of 18S:competi-
tor mix utilised in all the semi-quantitative analysis was 2:8 respectively as this ratio was found
to demonstrate equivalent specific intensities to those without the addition of 18S.
Next, we investigated the expression of CXCL9/10/11 in oral tissues from patients with
OLP, an inflammatory disease were IFN-γ is produced at high levels [40]. The greatest ratio
of the CXC ELR- chemokines in OLP tissues compared to the adjusted 18S was CXCL9, fol-
lowed by CXCL10, whereas CXCL11 was only minimally expressed in OLP (Fig 7 and
Table 1). However, CXCL11 expression was not detected semi-quantitatively at all in NOM,
and all OLP samples expressed CXCL11 without 18S /competitor whereas only faint expres-
sion for CXCL11 mRNA could be seen in normal oral mucosa samples. Conversely, CXCL9
and CXCL10 mRNA levels were present in NOM, however their ratios were substantially
higher in OLP than NOM tissue.
Fig 2. a) The concentration of CXCL9 produced by the H357 cell line stimulated with IFN-γ for 3, 6, 9,
24, 48 and 72 hours. b) The concentration of CXCL10 produced by the H357 cell line without (con) or
stimulated with IFN-γ (ifn) for 3, 6, 9, 24, 48 and 72 hours. Significant differences in chemokines production
between untreated cells and IFN-γ treated cell line are indicated as * = p<0.05 or ** = p<0.01. The ELISA is
the result of triplicate experiments, shown with ±SD.
doi:10.1371/journal.pone.0172821.g002
CXCL9/10/11 regulation in oral keratinocytes
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Fig 3. 18S (a), CXCL9 (b), CXCL10 (c) and CXCL11 (d) mRNA expression. mRNA expression in 3
different normal human oral keratinocytes (NHOK), either IFN-γ treated for 48 hours (ifn) or control cells that
were left untreated for 48hrs (con).
doi:10.1371/journal.pone.0172821.g003
CXCL9/10/11 regulation in oral keratinocytes
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Our data demonstrate that normal oral mucosa expresses low levels of CXCL9 and
CXCL10 chemokines that are significantly up-regulated in OLP tissues.
Discussion
This study was the first to demonstrate the induction of CXC ELR- chemokine release in
human primary oral keratinocytes as well as oral cancer cells after IFN-γ treatment. Further-
more, the ex-vivo analysis showed higher levels of all three the chemokines CXCL9/10/11 in
tissues from patients with OLP compared to normal oral mucosa, reflecting our results from
the cell culture model.
We assessed that IFN-γ treatment alone was sufficient to induce both CXCL9 and CXCL10
expression in oral epithelial primary cells. This confirms that oral keratinocytes are a respon-
sive cell type to such selective stimulation. Our results showed that these chemokines are
absent or only produced to a minimal degree in resting cells, but are induced after IFN-γ stim-
ulation, suggesting that oral epithelial cells may have more in common in terms of CXC ELR-
Fig 4. CXCL9/10 production in NHOK strains. In all the NHOK strains CXCL10 production was highly
significantly increased after IFN-γ stimulation compared to untreated cells (a). The level of CXCL9 production
in the stimulated cells was also highly significantly increased in all the cell lines compared to resting cells,
however, there was a substantially lower concentration of CXCL9 produced compared to CXCL10 in all the
primary cells (b).
doi:10.1371/journal.pone.0172821.g004
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chemokine production with the skin / bronchial epithelium rather than gut epithelium
[9,19,47,48].
IFN-γ-induced CXCL9 and CXCL10 mRNA has previously been found in glomerular cells
[20], fibroblasts [15], bronchial epithelial cells [19] and cutaneous epithelial cells [47] whereas
CXCL11 mRNA can be induced in primary oral epithelial cells under the influence of IFN-γ,
in common with monocytes, astrocytes [49], endothelial cells [17], cutaneous keratinocytes
[9,47] and bronchial epithelial cells [19].
In our study the levels of IFN-γ–induced CXCL10 were significantly higher than those of
CXCL9 in all primary oral epithelial cells. This was similar in pattern to the findings of Tensen
et al., in cutaneous keratinocytes [9]. However, the mRNA appears to decrease in cutaneous
keratinocytes after 12hours of stimulation [47], whereas in primary oral keratinocytes and
H357 cells there is still mRNA expression at 48hours post-treatment. However, the study of
cutaneous keratinocytes stimulated the cells with only 200U/ml IFN-gamma compared to
1000U/ml in this study and this increased concentration may account for the difference
We found that there was a well detectable level of CXCL10 mRNA transcript in unstimu-
lated cells, despite only low level of protein was produced. This correlates with the in vitro find-
ings of Boorsma et al. in cutaneous keratinocytes [50], although the level of protein secretion
in both the oral and cutaneous cells in this study paralleled with mRNA patterns.
In our study the peak production of both CXCL10 and CXCL9 was at 48 hours after IFN-γ
incubation, however, there was an increased production of CXCL10 after only 3 hours of IFN-
Fig 5. FACS profile of gated lymphocytes labelled with anti-CD4 and anti-CD45RA. migrated to a)
100nM CXCL12 (SDF-1alpha) and b) 1μg/ml CXCL10. c)/d) The normalised % migration of input PBMC to
CXCL10 and CXCL12. Basal migration is the migration to cell culture medium alone.
doi:10.1371/journal.pone.0172821.g005
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γ incubation. This pattern correlates with previous studies on stimulated bronchial epithelium
supernatant [19] and IFN-γ treated neutrophils [16].
The production of CXCL9/10/11 chemokines in oral cancer cells is also novel.
There is an early induction of CXCL9/10/11 mRNA in H357 cells after just 3 hours of incu-
bation with IFN-γ, and the expression increases until 24 hours for each chemokine. In con-
trast, there is no or little detectable mRNA for the control, untreated cells.
We found in this study that the prominent IFN-γ-induced chemokine, CXCL10, is chemo-
tactic for lymphocytes and especially T cells with memory cell characteristics. This is in agree-
ment with other studies that found CXCR3 is predominately expressed upon memory CD4
cells (and naïve and memory CD8+ cells) [11,51]. Therefore, production of CXCL10 in the
oral epithelium is likely to recruit cells with these characteristics to the epithelial area, and may
contribute to inflammatory conditions that are characterised by memory T cell infiltration
such as OLP.
A further mainstay of this study is the upregulation of CXC ELR- chemokines mRNA in
OLP tissue. CXCL9/10/11 chemokine expression were all up-regulated in OLP compared to
normal oral mucosal tissue.
In our study CXCL9 had the highest level of expression compared to 18S in OLP lesional
tissue, whereas CXCL11 was weakly expressed compared to CXCL9 and CXCL10. The ex vivo
results found in this study of OLP are consistent with previous immunohistochemical studies
in cutaneous lichen planus [9,31,36], and mucosal lichen planus [31,38,52] where CXCL9 was
the dominant chemokine expressed and CXCL11 was only expressed to a small degree. In
these studies CXCL9 was mainly found to be expressed by the dermal infiltrate, whereas
CXCL10 and CXCL11 was expressed by keratinocytes adjacent to the infiltrate.
In contrast, in other oral inflammatory conditions, such as periodontitis, there appears to
be a different chemokine profile with only few biopsy samples demonstrating CXCL10 expres-
sion in oral epithelium [39]. However, a study of inflamed gingival tissue found that there
were infiltrating CXCR3 cells present [53], suggesting that these cells can play a role in oral
Fig 6. a) The linear range of CXCL9 (a), CXCL10 (b), CXCL11 (c) mRNA expression in a representative
OLP sample. The samples were removed from the PCR machine every 2 cycles (from cycle 15–33). CXCL9
expression is located at 351 bp. b) The same process as for CXCL9 was carried out. The molecular weight of
CXCL10 expression is at 601 bp.
doi:10.1371/journal.pone.0172821.g006
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Fig 7. The semi-quantification of the CXC ELR- chemokines in oral inflammation. a) 18S, b) CXCL9, d)
CXCL10 and f) CXCL11 mRNA expression in 6 samples of oral lichen planus (OLP) (as a representative of 12
different cases) and 6 samples of normal oral mucosa (NOM). c) CXCL9, e) CXCL10 and g) CXCL11 mRNA
expression for the same cases with a 2:8 ratio of 18S:competitor (2:8 18S).
doi:10.1371/journal.pone.0172821.g007
Table 1. The semi-quantitative ratios of MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) mRNA expression in OLP and NOM tissue compared to
18S / 2:8 competitor mRNA expression.
P value
Number of samples quantified CXCL9 12 6
CXCL10 12 6
CXCL11 12 6
Ratio of 2:8 18S:chemokine CXCL9 0.71 (±0.47) 0.144 (±0.24) * (p = 0.01066395)
CXCL10 0.49 (±0.23) 0.166 (±0.27) * (p = 0.02650378)
CXCL11 0.048 (±0.121793) 0 p = 0.1808416
± standard deviation of the ratios is shown in brackets. Statistical significance is indicated as * = p<0.05.
doi:10.1371/journal.pone.0172821.t001
CXCL9/10/11 regulation in oral keratinocytes
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inflammation. This differential expression of chemokines in the 2 different oral disorders
would suggest there is a recruitment of different cell types, and this is probably important in
the pathogenesis of these conditions.
As IFN-γ production is a characteristic feature of Th1 cells, the fact that Th1 type cells are
located in this region leads to the possibility that these cells are CXCR3+ cells recruited by the
CXC ELR- chemokines. Furthermore, CXCL9/10/11 have shown to be antagonists for CCR3
bearing cells [54], a receptor associated with Th2 cells, which could further skew the reaction
in OLP to a Th1 reaction. These recruited Th1 cells could in turn induce the local production
of more CXCR3-binding chemokines through IFN-γ leading to the exacerbation of the
lesions.
Interestingly, this pattern of chemokine expression in OLP is similar in allergic contact der-
matitis [12,40], suggesting that OLP may well be caused by a hypersensitivity reaction to as yet
an unknown trigger.
As recent research suggests that OLP may be regarded as an autoimmune condition [52], is
it interesting to note that the expression of CXCR3-binding chemokines has also been associ-
ated in other T cell mediated autoimmune reactions besides OLP. In a murine model of auto-
immune disease the production of CXCL9/10/11 chemokines appears to reduce after 24 days
which corresponds to the destruction of the target organs in this condition [32].
CXCL9/10/11 chemokines are also noted to have antimicrobial activity, in a mechanism
similar to that of the defensins [55]. As proposed by Thornhill in 2001 [56], an oral autoim-
mune reaction could possibly be caused by local food antigens or the microbial flora; thus, one
can speculate that these chemokines could be induced in the early stages of OLP because of
their function as antimicrobial agents, although their chemotactic properties could eventually
lead to the large T cell infiltrate witnessed in overt OLP tissues. CXCL9 and CXCL10 are also
proposed to have a role in the latter stages of wound healing [57], correlating with a lympho-
cyte infiltration peaking at 14 days after wound damage.
In conclusion, the finding that there is an up-regulation of CXCL9, CXCL10 and CXCL11
in OLP compared to normal oral mucosa as well as in IFN-γ stimulated oral keratinocytes sug-
gest that these chemokines may play a role in determining the inflammatory infiltrate of OLP,
specifically in the migration of specific T cell subsets. CXCL10 was produced in large quantities
in oral epithelium in our studies, and was found to attract CD4+CD45RA- T cells, suggesting
that this chemokine could have a pivotal role in the accumulation of memory T cells in the
band-like infiltrate below the oral epithelium. Further studies are warranted to confirm this
novel hypothesis on the pathobiological mechanisms of OLP.
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